Ignite Creation Date:
2025-12-26 @ 10:45 PM
Ignite Modification Date:
2026-03-03 @ 8:18 PM
Study NCT ID:
NCT02996812
Status:
COMPLETED
Last Update Posted:
2024-12-04
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia
Sponsor:
Tracey McLaughlin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-15
First Submit QC Date:
None
Study First Post Date:
2016-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-02
Last Update Post Date:
2024-12-04
Last Update Post Date Type:
ACTUAL